International business sept october 2012 - bba v sem -handout format- ps
Handout (.ppt format, 9595.0 kb)
description
Transcript of Handout (.ppt format, 9595.0 kb)
Judith Fradkin, M.D.Director, Division of Diabetes,
Endocrinology, and Metabolic Diseases
National Institute ofDiabetes and
Digestive and Kidney Diseases
Diabetes and Obesity in WomenDiabetes and Obesity in Women
Diabetes: Diabetes: Scope of the ProblemScope of the Problem
• >17 million Americans
• Leading cause of:– Kidney failure, adult blindness, amputations
• Cardiovascular disease: main cause of death
• Estimated $132 billion health care costs
0
5
10
15
20
25
30
Peo
ple
(m
illi
on
s)
1960
1970
1980
1990
2000
2010
2020
2030
2040
2050
Diagnosed cases
Projected diagnosed cases
Prevalence of Diagnosed Diabetes in the United States
Diagnosed (1960-1998) and Projected Diagnosed (2000-2050) Cases
Data for 1960-1998 from the National Health Interview Survey, NCHS, CDC.
Projected data for 2000-2050 from Boyle JP, et al, Diabetes Care 24:1936-40, 2001.
Year
Estimated Growth in Type 2 Estimated Growth in Type 2 Diabetes and US Population Diabetes and US Population
From 2000-2050From 2000-2050
0
20
40
60
80
100
12020
00
2005
2010
2015
2020
2025
2030
2035
2040
2045
2050
Year
Per
cent
incr
ease
Type 2 DM
General population
Working age population (20-59)
Bagust A, et al. Diabetes 50, Suppl 2 A205, 2001
Prevalence of Diabetes by Race/Ethnicity and Sex
Gender Specific Effects of Diabetes
• Health risk to woman
• Health risk to offspring
• Prevention is possible
1 2 3 4 5 6 7Relative Risk
Adventist
Nurses
NHANES
Rancho
Framing
Chicago Ht
Cardiovascular Mortality: WomenDiabetes vs Nondiabetes
Diabetes and Atherosclerosis
• DM a CAD Risk Equivalent• Lose gender protection: equal age adjusted rates MI, stroke
claudication• Claudication increased 3.5-fold men and 8.6-fold women
(Framingham)• Mortality post MI double in diabetes• Mortality increased 1.4-fold for men and 1.9-fold women
(Italy) and 1.6-fold for men and 2.6-fold for women (Finland)
• CAD mortality decreasing in general population, steady in men with DM and increasing in women with DM (NHANES)
Source: National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
0
5
10
15
20
25
30
35
Black, not Hispanic
MalesFemalesMexicanAmerican
White, notHispanic
2010Target
Aspirin Therapy*: Persons with Diabetes, Age 40 years and Over, 1988-94
Age-adjusted percent
Total
*Took aspirin at least 15 times in past month. I 95% confidence interval.
The ABC’s of DiabetesThe ABC’s of DiabetesKnow Your NumbersKnow Your Numbers
AA is for A1C
BB is for Blood Pressure
CC is for Cholesterol
Gender Specific Effects on Acute Complications of T1D
• Adolescent girls had 2-3 fold increased risk DKA compared to boys or younger girls
• Adolescent girls had rates of hypoglycemia like DCCT conventional group while boys were similar to intensive group
• Hypothesis that girls skip insulin for fear of weight gain
Gestational Diabetes
• 14% of pregnancies• 135,000 women in U.S. annually• GDM has same risk factors as type 2 diabetes• Fetal macrosomia risk related to postprandial
glycemia• Increased diabetes in offspring• 60-90% risk of recurrence• risk of type 2 diabetes after pregnancy 30% over
10 years
Mother with Mother with DiabetesDiabetes
Woman with Woman with DiabetesDiabetes
Infant of Infant of Diabetic MotherDiabetic Mother
Diabetes in Pregnancy and Offspring: Diabetes in Pregnancy and Offspring: The Vicious CycleThe Vicious Cycle
Pettitt & Knowler, Pettitt & Knowler, J Obes Wt Reg J Obes Wt Reg 19881988
0
20
40
60
5-9 10-14 15-19 20-24 25-29
Age (years)
Prev
alen
ce (%
) nondiabeticprediabeticdiabetic
Diabetes in Offspring By Maternal Diabetes in Pregnancy
MotherMother
Birth Weight and Risk for Gestational Diabetes
• U shaped curve with increased risk at low birth weight and high birth weight
• Effect of high birth weight disappears with adjustment for maternal diabetes
• Susceptibility to diabetes and insulin resistance may be programmed in utero
0
10
20
30
10-19 20-29 30-39
Age (years)
Prev
alen
ce (%
)
>2 mo. Never
Prevalence of Diabetes Prevalence of Diabetes in Pima Indians by Infant Feedingin Pima Indians by Infant Feeding
Pettitt: Lancet, 1997Pettitt: Lancet, 1997
Breast FedBreast Fed
Adj. OR = 0.38 (0.16 – 0.89)Adj. OR = 0.38 (0.16 – 0.89)
0
5
15
25
10
20
30
Non-HispanicWhite
Non-HispanicBlack
Boys Aged 12-19 years
MexicanAmerican
P =<.001
P =<.001
P =.35
Non-HispanicWhite
Girls Aged 12-19 years
Non-HispanicBlack
MexicanAmerican
P =.10
P =.002
P =.08
Perc
enta
ge
Overweight Prevalence by Race/Ethnicity for Adolescent Boys and Girls
SOURCES: National Health and Nutrition Examination Survey,National Center for Health Statistics, CDC
NHANES III1988-1994NHANES1999-2000
Obesity and Women
• Major determinant of health related quality of life in women throughout the lifespan
• 34% of women vs 27.7% of men were obese in NHANES 1999-2000
• 6.3% of women vs 3.1% of men with class 3 obesity
• 15% of black women have class 3 obesity– 3-fold increase compared to non-Hispanic white women and Mexican American women
The Toll of Obesity
• Premature mortality: 280,000 deaths in U.S. annually
• Increased type 2 diabetes, CVD, arthritis, cancer• Strong correlation with low SES particularly in
women• Strong correlation with sedentary activities (TV
watching in women) and inverse correlation with physical activity
The Diabetes Prevention Program
A U.S. Randomized Clinical Trial to Prevent Type 2 Diabetes
in Persons at High Risk
Mean Weight Change from Baseline
-8
-7-6
-5
-4-3
-2
-10
1
Wei
gh
t C
han
ge
(Kg
)
0 6 12 18 24 30 36 42 48 Months
Lifestyle
Metformin
+Placebo
0 1 2 3 4
0
10
20
30
40
Placebo (n=1082)Metformin (n=1073, p<0.001 vs. Placebo)Lifestyle (n=1079, p<0.001 vs. Met , p<0.001 vs. Placebo )
Percent Developing Diabetes Percent Developing Diabetes
All participants
Years from randomization
Cu
mu
lati
ve i
nci
den
ce (
%)
Small Steps. Big Small Steps. Big Rewards.Rewards.
What’s Your Game Plan?What’s Your Game Plan?